Business · 26/10/2018
FDA Reopens Comment Period for Sucralfate Draft Guidance
The FDA is reopening the comment period for a revised draft product-specific guidance on Sucralfate, allowing industry to submit comments on the guidance following an FDA response to two citizen petitions.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →